The test is available to any woman from the week 10 of pregnancy onward.
The test tells you the possibility risk rate of chromosomal abnormalities with your baby. Although NIPT by GenePlanet is 99.02 % accurate for the three most common trisomies - Down Syndrome, Edwards Syndrome or Patau Syndrome, as a screening test it cannot tell with a 100 % sensitivity that your baby does or does not have one of the conditions. The extended test options also provide testing for sex chromosomal aneuploidies, other autosomal trisomies (T9, T16, T22) and more than 60 deletions and duplications.
In addition, the NIPT by GenePlanet can also provide gender information should you wish to know.
The test analyses cell-free fetal DNA that is present in the mother's blood circulation during pregnancy. By taking a small maternal blood sample, the test analyses this cell-free fetal DNA on genetic sequencing machines to see whether any of tested chromosomal abnormality is present.
For more information please visit the 'Science Behind NIPT by GenePlanet' page on our website or watch our introductory video where the test methodology is explained in further detail.
Our test is 99.02 % accurate for detection of Down Syndrome, Edwards Syndrome and Patau Syndrome. The sensitivity was validated based on two external validation studies.
It is important to note that NIPT by GenePlanet is a screening test, which means that it does not test with a 100 % sensitivity like an invasive diagnostic procedure, such as amniocentesis, does.
The results are available within 6-8 working days at the healthcare provider who conducted your test.
A false positive result is when the result comes back as positive for a certain condition when in fact subsequent confirmatory diagnostic testing shows the fetus do not have the condition.
NIPT by GenePlanet has a false positive rate of 0.05 % for T21 trisomy.
A diagnostic test tests with a 100 % sensitivity and tells you whether a certain condition is present or not. The disadvantage for diagnostic prenatal tests, such as amniocentesis, is that they carry the risk of miscarriage.
A screening test indicates the risk of having a condition, and while it may be highly accurate, it does not test with a 100 % sensitivity.
NIPT by GenePlanet is a screening test, so while it has a very high level of sensitivity (99.02 %) for detection of Down Syndrome, Edwards Syndrome and Patau Syndrome, it is not a diagnostic test. The advantage this test has over a diagnostic one is that is 100 % safe for both the mother and the fetus.
The price of the test varies depending on your country and your healthcare provider. Please contact your healthcare provider for more information. If you are not sure where your nearest NIPT by GenePlanet test provider is located, please contact us via the contact form on our website.
You should always review your results with your healthcare provider. We advise that in the event of a high-risk result, you undertake a confirmatory diagnostic testing.
Contact us, and we will gladly help you find the nearest open clinic.